DEC 03, 2020 8:30 AM PST

Oregon to Create Advisory Board for Psilocybin Mushroom Therapy

WRITTEN BY: Annie Lennon

Last month, Oregon became the first state in the US to legalize psilocybin mushrooms as a therapeutic treatment. Now, the state is recruiting for a 16-member Oregon psilocybin Therapy Board to design the requirements, specifications, and guidelines for psilocybin therapy in the state. 

The Oregon Health Authority (OHA) released the criteria for prospective members of the upcoming advisory board. There, they specify that physicians, psychologists, public health experts, scientific researchers, and representatives of state agencies, including OHA, may apply. They also invited those with experience in mycology, ethnobotany, psychopharmacology, and psilocybin harm reduction to apply, alongside members of the general public and representatives of Indian tribes. 

The OHA aims to establish the advisory board before January 2021, when they will begin the two-year process of specifying safety, practice, and training standards, alongside licensing specifications for facilitators, service centers, manufacturers, and testing laboratories. Following this process, they expect the therapy to be available in the first half of 2023. 

The creation of the board and criteria for its membership were stipulated under Measure 109, a bill that received the popular vote in Oregon in November. The bill also specified access to psilocybin-based therapy in a clinical context for adults over the age of 21 without any limitation on the type of condition to be treated. 

“We’re so pleased in the investment outlined in the Governor’s budget yesterday, which begins the important, two-year process to ensure that Oregon creates a safe, effective and equitable psilocybin therapy program,” said Sam Chapman, who was the Measure 109 campaign manager and will now work on implementing the program. 

“I look forward to working with the Governor, Legislature and the Oregon Health Authority in the months ahead to ensure a responsible implementation that prioritizes accessibility while maximizing safety."

 

Sources: Marijuana MomentYes 109Oregon.gov

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
NOV 08, 2020
Neuroscience
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
NOV 08, 2020
New Way to Restore Fatty Myelin Sheaths on Nerve Cells
Researchers from the F.M. Kirby Neurobiology Center in the US have discovered a new approach to restore myelin sheaths, ...
NOV 20, 2020
Drug Discovery & Development
Hyperbaric Oxygen Treatments Reverse Aging
NOV 20, 2020
Hyperbaric Oxygen Treatments Reverse Aging
Researchers from Israel have found that hyperbaric oxygen treatments (HBOT) in healthy aging adults can prevent blood ce ...
DEC 09, 2020
Drug Discovery & Development
Natural Sugar Alternative Stevia May Cause Gut Bacteria Imbalance
DEC 09, 2020
Natural Sugar Alternative Stevia May Cause Gut Bacteria Imbalance
Governments are keen to create regulations to reduce sugar intake. As such, companies are increasing their usage of arti ...
DEC 09, 2020
Technology
AI Helps Drug Combination Therapy in Cancer
DEC 09, 2020
AI Helps Drug Combination Therapy in Cancer
Healthcare providers opt to multiple of therapies for cancer patients—often containing combo drugs. Research has s ...
DEC 11, 2020
Drug Discovery & Development
Could Tomatoes Be Therapy for Parkinson?
DEC 11, 2020
Could Tomatoes Be Therapy for Parkinson?
Could tomatoes be the next Parkinson’s drug? Researchers have introduced novel use of tomatoes for therapy. Scient ...
DEC 31, 2020
Immunology
Arthritis Medication Resolves Previously Untreatable Skin Condition
DEC 31, 2020
Arthritis Medication Resolves Previously Untreatable Skin Condition
Bumpy, inflamed, ring-shaped lesions on the skin—granuloma annulare (GA) is a chronic, inflammatory skin condition ...
Loading Comments...